Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia.
Ruan Y, Kim HN, Ogana HA, Wan Z, Hurwitz S, Nichols C, Abdel-Azim N, Coba A, Seo S, Loh YE, Gang EJ, Abdel-Azim H, Hsieh CL, Lieber MR, Parekh C, Pal D, Bhojwani D, Durden DL, Kim YM.
Ruan Y, et al. Among authors: ogana ha.
Front Oncol. 2021 Dec 1;11:766888. doi: 10.3389/fonc.2021.766888. eCollection 2021.
Front Oncol. 2021.
PMID: 34926269
Free PMC article.